Indeed, TRiC subunits are significantly associated with aggressive cancer traits and poor outcomes in hepatocellular carcinoma [47], Ewing sarcoma [48], breast cancer [49, 50], neuroblastoma [51], gastric cancer [52], and lung adenocarcinoma [53]. This evidence concerns the gene MARVELD2 and hepatocellular carcinoma.